中国组织工程研究与临床康复
中國組織工程研究與臨床康複
중국조직공정연구여림상강복
JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH
2009年
47期
9349-9352
,共4页
微囊化%材料%胰岛%移植%糖尿病
微囊化%材料%胰島%移植%糖尿病
미낭화%재료%이도%이식%당뇨병
目的:评价当前国内外微囊化人工细胞技术在糖尿病中的应用效果.方法:检索PUBMED数据库中1980/2009有关人工细胞微囊技术进展在糖尿病中应用的文献,检索词"microcapsule,islet,transplantation",并限定文献语言种类为English:同时检索中国期刊全文数据库1999/2009有关人工细胞微囊技术进展在糖尿病中应用的文献,检索词为"微囊,胰岛,移植".按纳入与排除标准收集所有相关动物随机对照及临床试验,评价其质量及提取数据.结果:共纳入25篇文献,包括46例1型糖尿病患者,106只实验鼠,20头实验猪,25只实验猴.结果显示,与对照组相比,未囊化组与微囊化组胰岛细胞移植均可分泌胰岛素和降低血糖,微囊胰岛细胞组的胰岛细胞作用和存活时间更长.微囊具有较好的免疫隔离作用.结论:微囊胰岛细胞移植后能改善和调节糖尿病的糖代谢异常,且微囊的免疫隔离作用能消除或减轻受体对异体或异种免疫排斥反应,减少或消除对免疫抑制剂的依赖.合适的囊材、合理的工艺、先进的制囊设备和胰岛分离提纯技术、适宜的移植位置能增强微囊胰岛细胞的抗机械强度,提高生物相容性,提高胰岛细胞移植的成功率,改善人工胰岛细胞的功能,延长存活时间.
目的:評價噹前國內外微囊化人工細胞技術在糖尿病中的應用效果.方法:檢索PUBMED數據庫中1980/2009有關人工細胞微囊技術進展在糖尿病中應用的文獻,檢索詞"microcapsule,islet,transplantation",併限定文獻語言種類為English:同時檢索中國期刊全文數據庫1999/2009有關人工細胞微囊技術進展在糖尿病中應用的文獻,檢索詞為"微囊,胰島,移植".按納入與排除標準收集所有相關動物隨機對照及臨床試驗,評價其質量及提取數據.結果:共納入25篇文獻,包括46例1型糖尿病患者,106隻實驗鼠,20頭實驗豬,25隻實驗猴.結果顯示,與對照組相比,未囊化組與微囊化組胰島細胞移植均可分泌胰島素和降低血糖,微囊胰島細胞組的胰島細胞作用和存活時間更長.微囊具有較好的免疫隔離作用.結論:微囊胰島細胞移植後能改善和調節糖尿病的糖代謝異常,且微囊的免疫隔離作用能消除或減輕受體對異體或異種免疫排斥反應,減少或消除對免疫抑製劑的依賴.閤適的囊材、閤理的工藝、先進的製囊設備和胰島分離提純技術、適宜的移植位置能增彊微囊胰島細胞的抗機械彊度,提高生物相容性,提高胰島細胞移植的成功率,改善人工胰島細胞的功能,延長存活時間.
목적:평개당전국내외미낭화인공세포기술재당뇨병중적응용효과.방법:검색PUBMED수거고중1980/2009유관인공세포미낭기술진전재당뇨병중응용적문헌,검색사"microcapsule,islet,transplantation",병한정문헌어언충류위English:동시검색중국기간전문수거고1999/2009유관인공세포미낭기술진전재당뇨병중응용적문헌,검색사위"미낭,이도,이식".안납입여배제표준수집소유상관동물수궤대조급림상시험,평개기질량급제취수거.결과:공납입25편문헌,포괄46례1형당뇨병환자,106지실험서,20두실험저,25지실험후.결과현시,여대조조상비,미낭화조여미낭화조이도세포이식균가분비이도소화강저혈당,미낭이도세포조적이도세포작용화존활시간경장.미낭구유교호적면역격리작용.결론:미낭이도세포이식후능개선화조절당뇨병적당대사이상,차미낭적면역격리작용능소제혹감경수체대이체혹이충면역배척반응,감소혹소제대면역억제제적의뢰.합괄적낭재、합리적공예、선진적제낭설비화이도분리제순기술、괄의적이식위치능증강미낭이도세포적항궤계강도,제고생물상용성,제고이도세포이식적성공솔,개선인공이도세포적공능,연장존활시간.
OBJECTIVE: To systematically evaluate the application of microcapsuled cell or encystation materials for treating diabetes mellitus at hone or abroad in recent years.METHODS: A computer-based online search of PubMed database was undertaken to identify related articles about the microcapsulated cell or encystation material for treating diabetes mellitus published from 1980 to 2009 by using the key words of "microcapsulation, islet, transplantation" in English. Meanwhile, we search CNKI for relevant articles published between 1999 and 2009 with the same key words in Chinese. The related randomized, controlled, and clinical studies were collected according to conclusion and exclusion criteria.RESULTS: Among 25 articles, there were 46 patients with type I diabetes mellitus, 106 rats, 20 pigs, and 25 monkeys. The experimental results showed that both the microcapsulated islets and non-microcapsulated islets could secrete insulin and decrease blood glucose level. The normal blood glucose level with microcapulated islets could be maintained for a long time.Thus, microcapsule had a great immune isolation reaction.CONCLUSION: After transplantation, microencapsulated islet cells could improve and adjust abnormal glycometabolism of patients with diabetes mellitus; furthermore, the immunoisolation effect of microcapsule could eliminate or relieve the immunological rejection of receptors to allograft or xenograft, while it could also relieve or eliminate dependence on immunosuppressive drugs. Appropriate material of microcapsule, reasonable process, advanced equipment, advanced separation and purification technologies of islet, and suitable site for transplantation could improve the function of artificial islet cell, enhance the anti-machinery and chemical strength of microencapsuiated islet, improve biocompatibility, and prolong survival time.